Sterling & Wilson Solar Ltd, Akzo Nobel India Ltd, IRB Infrastructure Developers Ltd, India Cements Ltd are among the other stocks to see a surge in volumes on NSE today, 31 December 2020.

Sun Pharma Advanced Research Company Ltd registered volume of 77.04 lakh shares by 14:14 IST on NSE, a 14.53 fold spurt over two-week average daily volume of 5.30 lakh shares. The stock rose 8.32% to Rs.196.65. Volumes stood at 2.1 lakh shares in the last session.

Sterling & Wilson Solar Ltd witnessed volume of 54.58 lakh shares by 14:14 IST on NSE, a 7.45 times surge over two-week average daily volume of 7.33 lakh shares. The stock increased 10.73% to Rs.261.55. Volumes stood at 14.83 lakh shares in the last session.

Akzo Nobel India Ltd registered volume of 78058 shares by 14:14 IST on NSE, a 4.39 fold spurt over two-week average daily volume of 17769 shares. The stock rose 1.52% to Rs.2,437.95. Volumes stood at 28789 shares in the last session.

IRB Infrastructure Developers Ltd saw volume of 15.54 lakh shares by 14:14 IST on NSE, a 3.87 fold spurt over two-week average daily volume of 4.01 lakh shares. The stock increased 7.29% to Rs.117.75. Volumes stood at 2.07 lakh shares in the last session.

India Cements Ltd notched up volume of 188.62 lakh shares by 14:14 IST on NSE, a 3.76 fold spurt over two-week average daily volume of 50.16 lakh shares. The stock slipped 1.18% to Rs.172.00. Volumes stood at 308.63 lakh shares in the last session.

Powered by Capital Market - Live News

Net sales during the quarter rose 2.6% year-on-year (YoY) to Rs 17.64 crore. Total expenditure in Q2 September 2020 rose 24.8% to Rs 100.01 crore from Rs 80.11 crore in Q2 September 2019.

The company has a negative net worth as at 30 September 2020 and the current liabilities exceed current assets. The company, as per business plans, is in the process of evaluating various sources of raising funds for its operations. The company has also received a financial support letter from its parent company which is valid till time the company is able to raise funds from external sources, SPARC said.

SPARC is engaged in research and experimental development on natural sciences and engineering. The company operates through pharmaceuticals research and development segment.

Powered by Capital Market - Live News

Net Loss of Sun Pharma Advanced Research Company reported to Rs 83.49 crore in the quarter ended September 2020 as against net loss of Rs 63.16 crore during the previous quarter ended September 2019. Sales rose 2.62% to Rs 17.64 crore in the quarter ended September 2020 as against Rs 17.19 crore during the previous quarter ended September 2019.

Powered by Capital Market - Live News

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 9 November 2020.

Powered by Capital Market - Live News